Coin overview
BIO
Ended--
Last price (USDT)
1.79M
24h total (USDT)
5.76M
Total vol (USDT)
2024-12-25 09:00:00 ~ 2025-01-03 09:30:00
Trading time (UTC+0)
2025-01-03 11:00:00 ~ 2025-01-03 15:00:00
Delivery time (UTC+0)
Total supply3.32B
Resources
Introduction
BIO is an open network for biotech acceleration that directs funding to the best early-stage science. With BIO, patients, scientists and biotech builders can collectively fund, build & own portfolios of tokenized biotech projects. BIO protocol provides funding, incentives & liquidity to catalyze an on-chain scientific economy.
BIO rose above 0.188 USDT, with a 24-hour increase of over 30%.
``` September 6th news, MGBX current market data shows that BIO has risen above 0.188 USDT, now trading at 0.18 USDT, with a 24-hour increase of over 30%, and a circulating market value exceeding 330 million US dollars. Project introduction: BIO Protocol is a platform for funding and commercializing decentralized science (DeSci). ```
Polygon (POL) To Rise Higher? Key Emerging Fractal Signaling Potential Upside Move
Date: Sun, Aug 31, 2025 | 05:26 AM GMT The cryptocurrency market continues to remain in choppy waters as Ethereum (ETH) hovers around $4,450, down from its recent high of $4,954, marking a 7% weekly decline. Yet, ETH is trading green today, and several altcoins are showing notable upside moves. Among them, Polygon (POL) has jumped by 12%, drawing attention as its price chart begins to flash a bullish fractal setup that closely mirrors the breakout recently witnessed in Bio Protocol (BIO). Source: Coinmarketcap POL Mirrors BIO’s Breakout Structure BIO’s earlier price action provides a strong roadmap for POL’s potential trajectory. Earlier in June, BIO broke out of a falling wedge pattern, which is a classic bullish reversal signal. After the breakout, BIO consolidated just under a major resistance zone (highlighted in red). Once it cleared this barrier, the token ignited a sharp rally, reclaiming multiple resistance levels and ultimately delivering a staggering 319% move higher. BIO and POL Fractal Chart/Coinsprobe (Source: Tradingview) Now, POL appears to be tracing a nearly identical setup. The token has broken out of its own falling wedge and has established a support foundation around $0.2644. Currently trading above this level at $0.2717, POL is signaling early signs of strength in its structure — much like BIO did before its explosive run. What’s Next for POL? If this fractal continues to unfold, holding the $0.2644 support zone could serve as the springboard for the next rally leg. The next significant resistance areas lie near $0.3345 and $0.5170. A successful breakout through these zones could potentially pave the way for an 88% upside move from current levels, echoing the sharp trajectory BIO carved out earlier.
BIO - +43600% YOY - Due to 1-Year Surge and 1-Month Spike
On AUG 31 2025, BIO dropped by 159.12% within 24 hours to reach $0.191, BIO dropped by 1031.79% within 7 days, rose by 16490.94% within 1 month, and rose by 43600% within 1 year. BIO’s performance over the past year has been among the most striking in the digital asset space. Despite a sharp 24-hour drop and a 7-day decline, the 12-month cumulative gain of 43,600% has driven significant attention. This meteoric rise stands in contrast to a recent abrupt price correction that followed a 16,490.94% surge over the preceding month. The price movement underscores the volatile and unpredictable nature of the asset, which has experienced rapid and extreme swings. Technical observers have noted that such sharp reversals often coincide with overbought conditions and market sentiment shifts. The 1-month gain of 16,490.94% suggests an intense short-term buying frenzy, potentially triggered by algorithmic trading patterns or concentrated liquidity shifts. The subsequent drop implies that such rapid gains may not be sustainable without fundamental underpinnings. This pattern highlights the importance of risk management and volatility hedging for investors. The recent volatility raises questions about the sustainability of extreme price swings and the potential for similar patterns in other assets. The one-year move of 43,600% is particularly unusual and points to a possible structural shift in market dynamics, though not necessarily linked to intrinsic fundamentals. Backtest Hypothesis To evaluate whether similar price surges could be replicated or predicted using historical data, a backtesting strategy could be implemented. This would require identifying specific assets that achieved either a 16,490.94% gain within one month or a 43,600% gain over a 12-month period. To execute such a backtest, the first step is to define the exact tickers and the precise dates when these extreme price movements occurred. With this data, one could analyze the pre-movement technical indicators, volume patterns, and market sentiment metrics to determine if any consistent signals emerged before the surge. If such a dataset is not available, the strategy could be adapted to search for similar price patterns in a broader universe of assets. This would require specifying whether the search should focus on U.S.-listed securities or expand to a global market. Additionally, the definition of a “surge” must be clarified — typically, this would be measured using adjusted closing prices, but alternative metrics such as intraday high or volume-weighted average prices could be used depending on the strategy’s objective. By isolating these parameters and backtesting their predictive power, analysts can assess whether such extreme moves can be modeled and potentially leveraged for future trading decisions.
Blockchain’s Role in Democratizing Scientific Innovation: DMD Diamond and the Future of DeSci
The blockchain revolution is no longer confined to finance or art—it’s reshaping the very foundation of scientific innovation. At the forefront of this shift is DMD Diamond Blockchain, a Layer 1 infrastructure play positioned to capitalize on the explosive growth of the Decentralized Science (DeSci) market, projected to reach $800 million in the near term [1]. For investors, DMD represents a compelling opportunity to back a platform that is not only solving systemic inefficiencies in academia but also leveraging cutting-edge technology to democratize access to research, funding, and intellectual property. The DeSci Disruption: Why Blockchain Matters Traditional scientific research is plagued by paywalls, slow peer-review cycles, and centralized funding gatekeepers. DMD Diamond addresses these pain points by offering a censorship-resistant, open-access ecosystem where researchers can tokenize their work (papers, datasets, preprints) as NFTs, ensuring immutable proof of authorship and ownership [1]. This innovation alone could disrupt the $100 billion global academic publishing industry, which has long profited from restricting access to knowledge. Moreover, DMD’s built-in DAO infrastructure allows for community-driven funding. Scientists can submit proposals to decentralized autonomous organizations, where stakeholders—including philanthropists, institutions, and fellow researchers—vote on allocations in real time [2]. This model not only accelerates the pace of discovery but also aligns incentives across the ecosystem, fostering transparency and reducing bureaucratic friction. DMD’s Technical Edge: Scalability and Cost Efficiency What sets DMD apart from Ethereum-based DeSci platforms is its performance. The blockchain boasts 20x higher throughput than Ethereum, instant transaction finality, and fees that are a fraction of its competitors [3]. These metrics are critical for scientific workflows, where large datasets and frequent transactions are the norm. For context, Ethereum’s Layer 2 solutions (e.g., zkRollups) have improved scalability to ~10,000 TPS, but DMD’s native architecture already achieves similar efficiency without relying on external layers [4]. The platform’s recent v4 upgrade further solidifies its infrastructure role. A hybrid HBBFT consensus mechanism, combined with dPOS validator selection, ensures security while maintaining a capped supply of 4.38 million tokens [5]. This design mitigates inflationary pressures and aligns with DeSci’s long-term vision of sustainable growth. Market Valuation and Adoption Metrics Despite its early-stage market cap of BTC70.2581 (ranked #1756 on CoinGecko), DMD’s fully diluted valuation (FDV) of BTC79.5309 suggests significant upside potential [6]. The token’s low adoption rate relative to its theoretical maximum indicates untapped demand, particularly as DeSci gains traction among institutions and researchers. Real-world adoption is already accelerating. The platform’s grant program has incentivized developers to build dApps in DeFi, GameFi, and NFTs, expanding DMD’s utility beyond pure research [7]. Additionally, partnerships with multichain protocols like Pantos.io signal growing interoperability, which could attract Ethereum-based projects seeking lower costs and faster execution [5]. Competitor Landscape and Strategic Positioning While Ethereum-based DeSci platforms like Bio Protocol (BIO) and VitaDAO (VITA) have gained attention, DMD’s focus on end-to-end infrastructure gives it a unique edge. Unlike niche projects targeting specific disciplines (e.g., biotech or longevity), DMD offers a comprehensive ecosystem for open access, decentralized funding, and secure data sharing [8]. Its 12-year history as a Layer 1 blockchain also adds credibility, as it has weathered market cycles and evolved with technological advancements [5]. However, challenges remain. Regulatory uncertainty around DAO governance and the risk of fraudulent projects in the DeSci space could slow adoption. DMD mitigates these risks through its censorship-resistant design and transparent on-chain governance model [1]. The Investment Thesis For investors, DMD Diamond represents a strategic play on the intersection of blockchain and scientific innovation. Its technical advantages, real-world use cases, and alignment with a $800M+ market make it a high-conviction opportunity. The key question is timing: as DeSci adoption accelerates, will DMD’s early infrastructure lead translate into outsized returns? The data suggests yes. With a market cap still in early adoption and a roadmap that includes AI-driven tools like the “yesnoerror” agent for hypothesis validation [3], DMD is not just a blockchain—it’s a catalyst for redefining how science is conducted in the 21st century. Source: [1] DMD Diamond Blockchain Delivers On-Chain DeSci Tools [2] DMD Diamond Blockchain Project Disrupts Scientific Research [3] Open Science Gets a Blockchain Backbone—And an AI Sidekick [4] Blockchain Comparison: DMDv4 vs. Ethereum [5] DMD Diamond Marks 12-Year Milestone Ahead of V4 Upgrade [6] Diamond Price: DMD Live Price Chart, Market Cap & News [7] Build on DMD Diamond: New Grant Program to Fund dApps and Blockchain Tools [8] Top 10 Decentralized Science (DeSci) Tokens in June 2025
Neo (NEO) To Rally Further? Key Emerging Fractal Signaling Potential Upside Move
Date: Mon, Aug 25, 2025 | 05:55 AM GMT The cryptocurrency market is facing fresh volatility as Bitcoin (BTC) retraced to $112K from its 24-hour high of $115K, while Ethereum (ETH) slipped by 1.50%, adding downside pressure across major altcoins. However, Neo (NEO) stood out, surging by an impressive 16% today and extending its weekly rally to 34%. More importantly, NEO’s price chart is flashing a bullish setup that bears a striking resemblance to the breakout structure recently seen in Bio Protocol (BIO). Source: Coinmarketcap NEO Mirrors BIO’s Breakout Structure BIO’s recent move provides a textbook fractal example of how bullish reversals can unfold. After forming a falling wedge — a classic reversal formation — BIO consolidated beneath its 100-day moving average and red resistance zone before reclaiming the 200-day MA and igniting a parabolic rally of more than +300%. NEO now appears to be following a similar path. BIO and NEO Fractal Chart/Coinsprobe (Source: Tradingview) The token has successfully broken out of its falling wedge pattern, reclaimed both the 100-day and 200-day moving averages, and established a support base around the $8.0 red zone. Currently trading at $8.19, NEO is showing encouraging structural strength as buyers defend this breakout level. What’s Next for NEO? If the fractal continues to unfold, holding above the $8.0 support could serve as the launchpad for the next leg higher. The next significant resistance zones lie near $11.41 and $15.42, representing a potential 88% upside from current levels. That said, traders should exercise caution. A breakdown back below the red zone could invalidate the bullish setup, potentially dragging NEO into a prolonged consolidation phase.
Bio: AUBRAI Ignition Sale Oversubscribed by 13.8 Times with Less Than 2 Hours Remaining
According to Foresight News, Bio Protocol announced on X that over 1,660 users have participated in the AUBRAI Ignition Sale, with the subscription rate reaching 13.8 times, and less than two hours remaining until the end. The official statement noted that some frontend issues are being fixed, and if BioXP and BIO have already been deducted from users' wallets, these will be counted in this sale.
Bitget Trading Club Championship (Phase 6)—Grab a share of 80,000 BGB, up to 800 BGB per user!
The Bitget Trading Club Championship (Phase 6) is now live! Trade popular spot assets and share a 80,000 BGB airdrop pool with your club members. Top individual traders can earn up to 800 BGB! Promotion period: August 27, 2025, 12:00:00 AM–September 02, 2025, 11:59:59 PM (UTC+8) Join now Promotion rules: Activity 1: Club credits challenge 1. Daily credits accumulation: earn 1 credit each time your daily buy amount reaches a specified tier. You can earn multiple credits by hitting multiple tiers. For example, you can get 1 credit for buying $200 in a single day, 3 credits for buying $800, 6 credits for buying $6400, and so on. There's no cap on the number of credits you can earn daily! Daily buy amount Daily credits earned 200 1 400 2 800 3 1600 4 3200 5 6400 6 12,800 7 25,600 8 51,200 9 102,400 10 ... ... 2. Incentives calculation: My incentive = my credits ÷ total eligible credits × airdrop pool 3. Eligible trades: all spot-related trades are eligible, excluding stablecoins and zero-fee trading pairs. Eligible types include Bitget spot trading, spot Convert, spot margin trading, and small balance conversion. 4. Users who meet the minimum credit requirement will qualify to share 30,900 BGB. The qualifying threshold will be announced one working day after the promotion via Bitget's official social media channels. Stay tuned! Activity 2: Trading volume leaderboard battle 1. Rules: The user with the highest total spot buy volume during the promotion will receive 800 BGB. The user who ranks 2nd will receive 600 BGB. The total pool is 49,100 BGB, and rankings as well as incentives are as follows. Ranking Incentives 1st 800 BGB 2nd 600 BGB 3rd–5th 400 BGB 6th–10th 300 BGB 11th–50th 150 BGB 51st–100th 100 BGB 101st–300th 50 BGB 301th-1100th 30 BGB 2. Eligible trades: Only trades involving the designated assets (BTC/ETH/BGB/BIO/AAVE) are included. Eligible trading types include spot trading, spot margin trading, spot Convert, and small balance conversion. Note: Users must use the Join Now button to register for the promotion. Only spot orders placed after registration will be counted. This promotion is only open to active Bitget users who reach a total spot trading volume of over $5,000, or a total futures trading volume of over $100,000, or a maximum asset size of over $5,000 within the last 30 days. If you're not yet eligible, feel free to explore other promotions or increase your activity on Bitget to qualify for future promotions. During the promotion, spot orders are tracked daily from 12:00 AM to 11:59 PM (UTC+8) for credit calculation. Credits are awarded based on the actual order execution date. Incentives will be distributed to eligible accounts within five working days after the promotion ends. Users can check their incentives in their spot account. This promotion is exclusive to regular users. Sub-accounts, institutional users, PRO accounts, affiliates, and market makers are not eligible to participate. All participants must strictly comply with Bitget's terms and conditions. Bitget reserves the right to disqualify any user from participating in the promotion and confiscate their incentives if any fraudulent conduct, illegal activities (such as using multiple accounts to claim incentives), or other violations are found. Bitget will conduct a review of all users and promptly disqualify those who employ any technical means, including but not limited to electronic, robotic, repetitive, or automated methods, for the purpose of automated or repeated participation. Due to legal and regulatory requirements, some users may be unable to sign up for a Bitget account, or access may be temporarily restricted in certain countries or regions. Refer to Bitget's terms and conditions for the latest information. Bitget reserves the right to amend, revise, or cancel this promotion at any time without prior notice, at its sole discretion. Bitget reserves the right to the final interpretation of the promotion. Contact customer service if you have any questions. During the promotion period, the trading volume of users with a unified trading account as the main account may not be tracked accurately, which could impact incentive eligibility. We apologize for any inconvenience this may cause. Disclaimer Cryptocurrencies are subject to high market risk and volatility despite high growth potential. Users should conduct their own research and invest at their own discretion. Bitget shall not be liable for any investment losses. Join Bitget, the World's Leading Crypto Exchange and Web3 Company Sign up on Bitget now >>> Follow us on Twitter >>> Join our Community >>>
Bio Protocol launches Aubrai, the first-ever decentralized AI agent for longevity science
Bio Protocol has introduced Aubrai, the world’s first decentralized BioAgent designed to accelerate longevity research. Summary Co-developed with VitaDAO and informed by Dr. Aubrey de Grey’s longevity research, Aubrai leverages decentralized mechanisms to overcome traditional funding gaps and accelerate translational science. Aubrai can generate and validate research hypotheses, design wet-lab experiments, and securely encrypt data. Bio Protocol ( BIO ) has launched Aubrai, the world’s first decentralized AI agent designed to advance longevity research. The $AUBRAI Ignition Sale is live on Bio! Join the AUBRAI Sale: https://t.co/II8XyzdNwY > Commit $BIO & pledge BioXP before tomorrow Aug 26 11:00 UTC to qualify for an AUBRAI allocation > AUBRAI goes live for open-market trading TOMORROW shortly after the Ignition Sale closes https://t.co/GwZDqvIbGv — Bio Protocol (@BioProtocol) August 25, 2025 The launch price is set at 0.585 BIO per AUBRAI. The ongoing sale, conducted on the BASE blockchain, set a fundraising target of 234,000 BIO and has already been oversubscribed 13.5x. Source: bio.xyz About Bioprotocol’s Aubrai Co-developed by Bio Protocol and VitaDAO, Aubrai is the world’s first decentralized BioAgent, drawing knowledge from thousands of private lab notes, internal chats, and unpublished insights from the lab of Dr. Aubrey de Grey. De Grey is best known for pioneering longevity research through his Strategies for Engineered Negligible Senescence (SENS) framework and advocating the idea that aging is a disease that can be treated. “The consequences of traditional financing are a chronic funding gap, over-reliance on philanthropy, and a ‘valley of death’ between discovery and the clinic. That’s why we champion alternative mechanisms – DAOs, longevity-focused venture funds, and DeSci platforms – which can tolerate long horizons, align incentives around societal benefit, and crowd-source risk,” de Grey told CoinDesk in an interview. Aubrai functions as an on-chain AI co-scientist. It can generate and validate hypotheses, design wet-lab experiments, and encrypt data to protect trade secrets while enriching research outputs. At the heart of Aubrai’s mission is the Robust Mouse Rejuvenation (RMR2) project — de Grey’s ambitious study aiming to double the remaining lifespan of middle-aged mice. Aubrai has already demonstrated its capabilities in the RMR2 study, suggesting methodological tweaks and flagging dosing caveats. AUBRAI token holders gain governance rights over the agent’s research outputs. They also share in potential revenues from discoveries commercialized by the project.
Polygon (POL) To Rally Higher? Key Emerging Fractal Signaling Potential Upside Move
Date: Fri, Aug 22, 2025 | 06:25 PM GMT The cryptocurrency market turned bullish in the last hour after Jerome Powell hinted at potential rate cuts in September during today’s Jackson Hole event. Following the remarks, Ethereum (ETH) surged over 7% past $4,600, fueling strong momentum across altcoins , including Polygon (POL). POL has gained 6% in the past 24 hours, and its chart is now showing a bullish fractal structure that closely mirrors the breakout recently witnessed in Bio Protocol (BIO). Source: Coinmarketcap POL Mirrors BIO’s Breakout Structure BIO’s earlier price action offers a roadmap for POL’s potential. Earlier this year, BIO broke out of a falling wedge pattern, a classic bullish reversal setup. After the breakout, BIO consolidated just under a major resistance zone (highlighted in red). Once it cleared this barrier, the token accelerated sharply, reclaiming multiple resistance levels and ultimately delivering a 240% rally. BIO and POL Fractal Chart/Coinsprobe (Source: Tradingview) POL appears to be tracing the same trajectory. The token has already broken out of its own falling wedge formation and is currently pressing against a critical resistance zone near $0.2635, marked in red on the chart. What’s Next for POL? If this fractal continues to play out, a decisive breakout above $0.2635 could be the spark for a new bullish wave. The next upside targets sit at $0.3345 and $0.5170, representing a potential 104% move higher from current levels, should POL replicate BIO’s explosive pattern.
Saga (SAGA) To Rise Higher? Key Emerging Fractal Signaling Potential Bullish Move
Date: Sun, Aug 24, 2025 | 10:20 AM GMT The cryptocurrency market is taking a breather today after a strong rally triggered by Jerome Powell’s comments at the Jackson Hole event, where he hinted at potential rate cuts in September. Ethereum (ETH) briefly touched a new all-time high of $4,878 before cooling off to around $4,740, but the bullish energy has already sparked momentum across several altcoins . Among them, Saga (SAGA) is drawing attention as its chart structure is beginning to mirror the explosive breakout that recently played out in Bio Protocol (BIO). Source: Coinmarketcap SAGA Mirrors BIO’s Breakout Structure BIO’s price action serves as a textbook example of a fractal in play. After forming a falling wedge, a well-known bullish reversal pattern, BIO consolidated below its 100-day moving average and red resistance zone before reclaiming the 200-day MA and eventually launching into a parabolic rally of more than 300%. BIO and SAGA Fractal Chart/Coinsprobe (Source: Tradingview) Now, Saga’s daily chart appears to be tracing an eerily similar path. The token has already broken out of its own falling wedge and is currently hovering near its 100-day moving average, with immediate resistance at the red horizontal zone and the 200-day MA around $0.3354. This setup strongly resembles the pre-breakout conditions that fueled BIO’s massive upside surge. What’s Next for SAGA? If history repeats and SAGA continues to follow BIO’s fractal, the next key step would be a confirmed breakout above the 200-day MA. A decisive reclaim of this level could trigger strong upside momentum and potentially propel SAGA toward the $1.23 region, mirroring the explosive trajectory of BIO. On the flip side, failure to clear the 200-day MA could keep SAGA trading sideways and delay the bullish scenario. Traders should closely watch how price reacts around these critical moving averages.
Scroll (SCR) To Rally Higher? Key Emerging Fractal Signaling Potential Upside Move
Date: Thu, Aug 21, 2025 | 08:56 AM GMT The cryptocurrency market is bouncing back from its recent dip as Ethereum (ETH) reclaims $4,300, registering a 3% daily gain. This upside momentum is spilling over into altcoins , with Scroll (SCR) emerging as one of the notable movers. SCR surged by an impressive 14% today, and its chart is now flashing a bullish technical setup that strongly resembles the breakout structure seen in Bio Protocol (BIO) in this week. Source: Coinmarketcap SCR Mirrors BIO’s Breakout Structure BIO provides a valuable fractal reference. After forming a falling wedge pattern breakout—a well-known bullish reversal signal—BIO consolidated beneath a red-marked resistance zone before reclaiming multiple resistance levels. The breakout fueled a powerful 124% rally in just weeks. BIO and SCR Fractal Chart/Coinsprobe (Source: Tradingview) Now, SCR is beginning to trace a similar path. The token has broken out of its falling wedge pattern and has established a support foundation around the red zone at $0.347. Currently, SCR is trading above that level at $0.41, signaling strength in its price structure. What’s Next for SCR? If the fractal continues to play out, holding this $0.357 support zone could serve as the springboard for the next rally leg. The next major resistance lies near $0.692, which would represent an 85% upside from current levels. However, traders should remain cautious. A dip back below the red zone support could invalidate the bullish setup and push SCR into deeper consolidation. Disclaimer: This article is for informational purposes only and not financial advice. Always conduct your own research before investing in cryptocurrencies.
Bio Protocol to Launch First BioAgent Sale Project Aubrai, with 20% of Total Supply Allocated for Sale
Foresight News reports that the decentralized science (DeSci) platform Bio Protocol will launch its first BioAgent sale project, Aubrai. Aubrai has a total supply of 2 million tokens, of which 20% will be allocated for sale, 6% for the liquidity pool, 15% for the treasury, 20.1% for initial backers, 10% for LEVF, 22% for VitaDAO, and 6.9% for Bio Protocol. The token TGE is scheduled for August 25. Aubrai is a decentralized scientific agent jointly developed by VitaDAO and BIO, aimed at combating human aging.
Bio Protocol Launches Token Launchpad, Allocation Depends on Staked BioXP Shares
BlockBeats News, August 22 — DeSci protocol Bio Protocol has recently launched a token launch platform, with its first project being Aubrai. Users can obtain allocation for new token issuances by staking BioXP, and can acquire tokens by contributing BIO. The final allocation depends on the amount of BioXP staked. BioXP can be obtained through the following methods: staking Bio or Bio ecosystem assets; social participation (“Yapping”); DeSci score (purchasing ecosystem asset tokens, participating in past and upcoming sales on the Bio token launch platform, etc.); retroactive rewards (participating in Bio auctions to claim BIOXP); and project curation in Bio Protocol V1, among others. The first BioAgent Launch project, Aubrai, will have a 24-hour sale period, with the opening time to be announced separately. The AUBRAI token will be listed immediately after the sale concludes. Additionally, according to market data, BIO’s 24-hour price increase has expanded to 25%, with its market capitalization rebounding to $345 million.
Top 3 Altcoins Accumulated Off Exchanges in Mid-August
By the third week of August, several altcoins experienced a sharp drop in exchange reserves. This trend reflects growing demand for accumulation and off-exchange holding. The shift is especially notable as the so-called altcoin season has become increasingly selective. Which tokens are seeing this surge in accumulation, and what factors drive investor optimism? 1. Ethena (ENA) Data from Santiment shows that Ethena (ENA) exchange reserves fell from 1.3 billion to 1.15 billion during the third week of August. In other words, 150 million ENA left centralized exchanges. This happened while ENA’s price surged 30% in August, climbing from $0.51 to $0.65. ENA Supply on Exchanges. Source: Santiment. The reserve drop coincided with the Ethena Foundation announcing a $260 million buyback program. The plan allocates around $5 million daily to repurchase ENA from the market. Tokenomist estimates the buyback could remove 3.48% of the circulating supply. This absorption of sell pressure boosts long-term investor confidence. In addition, Ethena crossed major milestones in August. Revenue surpassed $500 million, while USDe supply reached a record high of $11.7 billion. Together, these drivers fueled ENA accumulation and exchange reserve declines. 2. BIO Protocol (BIO) BIO Protocol, a leading project in the DeSci sector, delivered an exceptional performance in August with gains of over 265%. Alongside the price rally, exchange reserves fell sharply. From early August to now, reserves dropped from 380 million to 294 million BIO — a more than 22% decline. The third week of August saw the most dramatic movement. Investors withdrew 42 million BIO in just one week, pushing exchange reserves to their lowest level this year. BIO Supply on Exchanges. Source: Santiment. Several catalysts explain this accumulation wave. BIO launched a staking program early in August that attracted over 25 million tokens. Additionally, Arthur Hayes invested $1 million into BIO this week, reigniting market attention. Bio Protocol also rolled out a new way to reach new investors. Users are asked to discuss the project on social media to earn BioXP, which gives them access to the first BioAgent sales. These factors combined to boost visibility, attract new investors, and accelerate accumulation. 3. API3 API3, an oracle-focused project, regained investor interest in August, sending its price up more than 130%. At the same time, exchange reserves fell to their lowest point this year. The third week of August marked a turning point. Over 9 million API3 were withdrawn from exchanges, reducing exchange supply to just 17.19 million. API3 Supply on Exchanges. Source: Santiment. The catalyst was Upbit’s listing of API3. According to the BeInCrypto report, the token’s price jumped over 120% immediately after the listing. Investor focus on the Oracle sector also increased due to Chainlink’s (LINK) rally. LINK’s strong performance in the past month spilled over into related projects. Data from Artemis confirmed Oracle was the market’s best-performing sector in August. The surge in API3 accumulation has kept its price trading steady at above $1.50. These three altcoins highlight different drivers behind August’s selective altcoin rally. While a broad-based altcoin season has yet to emerge, projects with unique catalysts — whether buyback programs, staking incentives, or an exchange listing — are attracting investor attention and capital.
Chromia (CHR) To Rally Higher? Key Emerging Fractal Signaling Potential Upside Move
Date: Thu, Aug 21, 2025 | 06:04 AM GMT The cryptocurrency market is rebounding from the recent pullback as Ethereum (ETH) climbs back to $4,300, posting a 3% daily gain. This momentum has lifted sentiment across the broader altcoin market, including Chromia (CHR). CHR has surged by an impressive 10% in the past 24 hours and is now showing a bullish technical structure that bears a striking resemblance to the breakout recently seen in Bio Protocol (BIO). Source: Coinmarketcap CHR Mirrors BIO’s Breakout Structure BIO’s price action provides a useful roadmap. Earlier this year, BIO broke out of a classic falling wedge pattern—a well-recognized bullish reversal formation. After the breakout, the token consolidated just below a resistance zone (highlighted in red on the chart). Once this barrier gave way, BIO regained strong momentum, reclaiming multiple resistance levels and ultimately delivering a 124% rally. BIO and CHR Fractal Chart/Coinsprobe (Source: Tradingview) Now, CHR is beginning to follow the same path. The token has already broken out of its own falling wedge pattern and is currently testing a critical resistance zone around $0.1083—marked in red on the chart. What’s Next for CHR? If this fractal continues to unfold, a successful breakout above $0.1083 could act as the catalyst for a fresh rally. From there, CHR could climb toward the next resistance levels at $0.1457 and $0.2337—a potential 122% upside from current prices, mirroring BIO’s explosive move.
BIO price forms a golden cross, can it rally to $0.30 as whales buy?BIO price forms a golden cross
BIO price looks poised to confirm a golden cross amid continued whale accumulation. Can it rally to $0.30 in the coming weeks? Summary Bio Protocol is up over 80% in the past week and has hit a six-month high today. Whales and high-profile figures have continued investing in BIO. A golden cross has formed on the daily chart, supported by other bullish technicals. According to data from crypto.news, Bio Protocol ( BIO ) rallied over 80% in the past 7 days, trading at $0.186, its highest level in six months. As of press time, its monthly gains stand at 175% while its year-to-date gains are over 340%. BIO crypto has rallied as whales and public figures show strong demand for the token. As per data from blockchain analytics platform Nansen, the balance of tokens held by whale wallets has increased to 21.94 million, up from 18.72 million recorded 7 days earlier and significantly higher than 2.03 million a month ago. Such strong accumulation by whales is often seen as a vote of confidence in the token’s outlook, creating a feedback loop that draws in retail investors and fuels further price appreciation. Source: Nansen The balance held by public figures has gone up to 7.66 million from just around 3,900 tokens held just a week earlier. BIO token also gained traction as the balance held by exchanges dropped 11.6%, from 471 million on Aug. 15 to just over 414 million at the time of writing. A decline in exchange balances typically suggests that investors are moving tokens into their own wallets, reducing the available supply on trading platforms. This could lower selling pressure and potentially support further price gains. A more recent catalyst that could be driving the token’s gains is the launch of Bio Protocol’s first BioAgent, Aubrai, yesterday, Aug. 21. The debut linked BIO’s utility to real biotech applications , boosting demand for the token. BIO price forms a golden cross BIO price had been consolidating within the $0.040–$0.100 range since early March before breaking out of this accumulation zone in August, following the confirmation of a double-bottom pattern on the daily chart—a formation typically associated with trend reversals and renewed buying momentum. BIO price forms a golden cross after it breaks out of a multimonth accumulation zone on the daily chart — Aug. 22 | Source: crypto.news The breakout has been reinforced by the emergence of a golden cross, as the 50-day simple moving average crossed above the 200-day moving average. This signal is generally viewed as a strong indicator of sustained bullish momentum. Supporting indicators such as the MACD and RSI are also trending higher, underscoring the strength of the ongoing uptrend. BIO MACD and RSI chart — Aug. 22 | Source: crypto.news From a technical perspective, the next key upside target lies near the $0.30 psychological level, which also coincides with the 1.618 Fibonacci extension. A move to this zone would represent an additional 67% advance from current price levels. However, if bullish momentum weakens, a decisive drop below the $0.10 psychological threshold, closely aligned with the 38.2% Fibonacci retracement, would invalidate this bullish setup and suggest a deeper correction.
Phala Network (PHA) To Rally Higher? Key Fractal Pattern Signals Potential Upside Move
Date: Thu, Aug 21, 2025 | 06:45 AM GMT The cryptocurrency market is rebounding from the recent dip as Ethereum (ETH) reclaims $4,300, notching a 3% daily gain. This strength has carried into the broader altcoin market, with Phala Network (PHA) now showing early signs of a potential breakout. PHA climbed 4% in the last 24 hours, and its price structure is beginning to resemble a bullish fractal pattern recently confirmed in Bio Protocol (BIO). Source: Coinmarketcap PHA Mirrors BIO’s Breakout Structure BIO’s chart has become a valuable reference point for traders. Earlier this year, BIO broke out of a classic falling wedge pattern—a bullish reversal formation. After consolidating beneath a red-marked resistance zone, the token powered higher, reclaiming multiple resistance levels and ultimately rallying by an impressive 124%. BIO and PHA Fractal Chart/Coinsprobe (Source: Tradingview) PHA appears to be walking the same path. It has also completed a breakout from a falling wedge structure and is now trading just below its immediate red resistance zone at $0.13, currently priced around $0.1186. What’s Next for PHA? If the fractal continues to play out, a successful breakout above $0.13 could serve as the trigger for a stronger rally. From there, PHA could target the next resistance levels at $0.1625 and $0.2058, which would represent a potential 72% upside from current prices.
Bio Protocol (BIO) To Soar Further? Key Harmonic Pattern Signals Potential Upside Move
Date: Tue, Aug 19, 2025 | 06:50 AM GMT The cryptocurrency market is experiencing notable selling pressure as Ethereum (ETH) slips back to $4,250 from its recent high of $4,780. This weakness has extended to several major altcoins . Yet, despite the broader pullback, Bio Protocol (BIO) has managed to remain resilient, posting a 10% gain on the day and extending its monthly rally to over 100%. Adding to the bullish case, BIO’s chart is now highlighting a harmonic formation that suggests further upside could be on the horizon. Source: Coinmarketcap Harmonic Pattern Hints at Potential Bounce On the 4-hour chart, BIO is forming a Bearish ABCD harmonic pattern. While technically labeled as bearish, this setup usually involves a strong bullish CD-leg rally before the Potential Reversal Zone (PRZ) becomes relevant. The structure began with a rally from Point A near $0.0559 to Point B, before BIO retraced to Point C around $0.0956, where buyers re-entered with conviction. Since then, the token has surged higher and is currently trading near $0.1380, with price action confirming the unfolding of the CD leg. Bio Protocol (BIO) Daily Chart/Coinsprobe (Source: Tradingview) The 1.90 Fibonacci extension of the BC leg projects Point D near $0.1787, marking a key upside target that traders are closely eyeing as the next potential resistance zone. What’s Next for BIO? If bullish momentum continues, BIO could push toward the $0.1787 PRZ, a level that could serve as both a profit-taking zone and a test of market strength. Historically, harmonic patterns often encounter heavy resistance at these completion zones, leading to either consolidation or a corrective pullback.
Memecoin (MEME) To Rally Higher? Key Emerging Fractal Signaling Potential Upside Move
Date: Wed, Aug 20, 2025 | 05:10 PM GMT The cryptocurrency market is staging a notable rebound from the recent dip as Ethereum (ETH) reclaims $4,300, marking a 3.5% daily jump. This strength has spilled over into the major memecoins, including Memecoin (MEME). MEME has entered bullish territory, recording a solid 34% rally in just a single day, and is now flashing a technical setup that closely resembles the breakout structure recently seen in Bio Protocol (BIO). Source: Coinmarketcap MEME Mirrors BIO’s Breakout Structure BIO’s chart offers a valuable reference point. After breaking out of a classic falling wedge pattern—a well-known bullish reversal formation—BIO quickly regained momentum by bouncing off the 100-day moving average. From there, it reclaimed multiple resistance zones and ultimately rallied by nearly 68%. MEME and BIO Fractal Chart/Coinsprobe (Source: Tradingview) Now, MEME is starting to carve out the same path. The token has already broken out of its falling wedge formation and successfully reclaimed its 100-day moving average. This technical move propelled MEME past its first resistance at $0.0026, with the token now trading above it at $0.00275. What’s Next for MEME? If this emerging fractal continues to unfold, MEME could extend its rally toward the next resistance at $0.0038. A short-term retest of the first resistance zone would not be unusual before the token attempts a fresh push higher. Beyond that, a move toward the third resistance at $0.0050 remains possible—representing a potential 73% upside from current levels.
Data: Arthur Hayes Suspected of Accumulating 7.66 Million BIO Tokens Worth Approximately $1.1 Million
According to ChainCatcher, on-chain analyst @ai_9684xtpa has monitored that Arthur Hayes allegedly opened a position of 7.66 million BIO tokens, worth $1.1 million, about half an hour ago. Since August 10, Arthur Hayes has spent a total of $14.37 million to purchase six Ethereum ecosystem tokens. Among them, only PENDLE appears to have been partially sold (the flow cannot be confirmed due to market maker transactions), while the remaining tokens are still being held.
Filled orders
Delivery scenarios